Using Vanrx Workcells, pharmaceutical companies can bring injectable medicines to market faster. Short changeover times and flexible systems enable agile manufacturing.
Industry magazines Pharmaceutical Manufacturing and Pharmaceutical Technology recently published articles about smarter contamination control and current aseptic filling challenges, respectively. Vanrx is featured in both articles, providing our perspective and solutions to help manufacturing leaders navigate the current landscape.Read More
Vanrx recently hosted its first User Group meeting, with customers and members of the Matrix Alliance partnership, coming to Whistler, Canada for two days of collaborative discussion.Read More
Fujifilm Diosynth has expanded its fill/finish capabilities for late stage and commercial gene therapies and viral vaccines using Vanrx's SA25 Aseptic Filling Workcell.Read More
Patheon, an international CDMO, recently published a case study of its experience installing an SA25 Aseptic Filling Workcell at one of its U.S. sites. To address the issue of human involvement in the filling process, the company successfully implemented a robotic filling line that operates in a closed isolator environment with no glove ports. This case study takes a look at the technology involved and highlights the implementation team’s experience with installation and qualification.Read the case study
The new white paper Aseptic Filling for Personalized Medicines describes a new solution for the aseptic filling of cell and gene therapies, immuno-oncology, mRNA and other modalities where manufacturing creates a therapy for a single patient.
A new gloveless robotic isolator for aseptic filling is particularly cost-effective and agile, helping companies process multiple patients per day within a single machine.Download the white paper
Jun 26 - Jun 27, 2018
Sep 4 - Sep 7, 2018
Boston, MA, USA
Sep 26 - Sep 26, 2018
Foxborough, MA, USA
E152 (East Hall)
Get a detailed view of how Aseptic Filling Workcells compare to conventional technologies and help bring drug products to market faster.Download the white paper
Our team members have developed and brought complex drug products to market. We know what you need now, and are designing for the future.